A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Inhalers for COPD provide steroids ... Inhalers come in three main types: metered-dose inhaler (MDI) dry powder inhaler (DPI) soft mist inhaler (SMI) Keep reading to learn about each type of ...

In addition to the asthma and COPD program, Transpire Bio is developing ... Transpire Bio’s innovative technology portfolio includes dry powder inhalers, metered-dose inhalers, and soft-mist ...

The growing incidence of asthma, COPD, and allergies has created a ... Innovations such as dry powder inhalers, soft mist inhalers, and metered-dose inhalers are making it easier for patients ...

GSK, leading the COPD market with its Trelegy Ellipta inhaler ... choosing the best therapy for each patient. "Are dry powder inhalers the key to sustainable respiratory care?" ...

As the prevalence of COPD rises with age ... a cost-effective alternative to pressurized metered-dose inhaler (pMDI) and dry powder inhaler (DPI) devices. DPI device availability is limited ...

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled ...

In addition to the asthma and COPD program, Transpire Bio is developing therapies ... Transpire Bio's innovative technology portfolio includes dry powder inhalers, metered-dose inhalers, and soft-mist ...

Conclusion: Budesonide Clickhaler® and budesonide Turbuhaler® dry powder inhalers demonstrated similar pharmacokinetic profiles, pulmonary bioavailability and systemic activity. As this was a ...

MDR Certification Strengthens Resyca’s Leadership in Soft Mist Drug-Device Combination Products ENSCHEDE, NL / ACCESS ...

Undoubtedly there exists a need to improve the care of and outcomes for children who are suffering from asthma. This blog ...

A new study suggests COPD patients experience improved lung ... in a single once-daily dose in GSK’s Ellipta dry powder inhaler. Novartis says its results support recommendations put forward ...